JAK Inhibitors: Back to Small Molecules for the Treatment of IBD

por Panés, Julian, Vermeire, Severine
Publicado 2020

Gram-Negative Enterobacteria Induce Tolerogenic Maturation in Dexamethasone Conditioned Dendritic Cells

por Cabezón, Raquel, Ricart, Elena, España, Carolina, Panés, Julián, Benitez-Ribas, Daniel
Publicado 2012

Perception gaps between patients with ulcerative colitis and healthcare professionals: an online survey

por Schreiber, Stefan, Panés, Julián, Louis, Edouard, Holley, Derek, Buch, Mandy, Paridaens, Kristine
Publicado 2012

Communication Between Physicians and Patients with Ulcerative Colitis: Reflections and Insights from a Qualitative Study of In-Office Patient–Physician Visits

por Rubin, David T., Dubinsky, Marla C., Martino, Steve, Hewett, Kathleen A., Panés, Julian
Publicado 2017

Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes

por Panés, Julián, Su, Chinyu, Bushmakin, Andrew G, Cappelleri, Joseph C, Mamolo, Carla, Healey, Paul
Publicado 2015

Burden and outcomes for complex perianal fistulas in Crohn’s disease: Systematic review

por Panes, Julian, Reinisch, Walter, Rupniewska, Ewa, Khan, Shahnaz, Forns, Joan, Khalid, Javaria Mona, Bojic, Daniela, Patel, Haridarshan
Publicado 2018

Ulcerative Colitis-Symptom Questionnaire: Valid for Use in Adults with Moderately to Severely Active Ulcerative Colitis

por Panes, Julian, Otley, Anthony, Sanchez Gonzalez, Yuri, Fitzgerald, Kristina, Zhou, Wen, Ilo, Dapo, Brion, Triza, Tahir, Muna J.
Publicado 2023

Health-Related Quality of Life Outcomes With Tofacitinib Treatment in Patients With Ulcerative Colitis in the Open-Label Extension Study, OCTAVE Open

por Biedermann, Luc, Dubinsky, Marla C, Vermeire, Séverine, Fellmann, Marc, Gardiner, Sean, Hur, Peter, Mundayat, Rajiv, Panés, Julian, Rubin, David T
Publicado 2022

Upadacitinib Treatment Improves Symptoms of Bowel Urgency and Abdominal Pain, and Correlates With Quality of Life Improvements in Patients With Moderate to Severe Ulcerative Coliti...

por Ghosh, Subrata, Sanchez Gonzalez, Yuri, Zhou, Wen, Clark, Ryan, Xie, Wangang, Louis, Edouard, Loftus, Edward V, Panes, Julian, Danese, Silvio
Publicado 2021

Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn’s Disease: ADMIRE-CD Ph...

por Garcia-Olmo, Damián, Gilaberte, Inmaculada, Binek, Matthias, D´Hoore, André J.L., Lindner, Dirk, Selvaggi, Francesco, Spinelli, Antonino, Panés, Julian
Publicado 2022

Modified Mayo score versus Mayo score for evaluation of treatment efficacy in patients with ulcerative colitis: data from the tofacitinib OCTAVE program

por Sandborn, William J., Sands, Bruce E., Vermeire, Séverine, Leung, Yvette, Guo, Xiang, Modesto, Irene, Su, Chinyu, Wang, Wenjin, Panés, Julian
Publicado 2022

Disease Activity and Health-related Quality of Life Relationships with Work Productivity in Patients with Ulcerative Colitis in OCTAVE Induction 1 and 2 and OCTAVE Sustain

por Targownik, Laura, Dubinsky, Marla C, Steinwurz, Flavio, Bushmakin, Andrew G, Cappelleri, Joseph C, Tai, Elaine, Gardiner, Sean, Hur, Peter, Panés, Julian
Publicado 2022

Predictors of bowel damage in the long-term progression of Crohn’s disease

por Fernández-Clotet, Agnes, Panés, Julian, Ricart, Elena, Castro-Poceiro, Jesús, Masamunt, Maria Carme, Rodríguez, Sonia, Caballol, Berta, Ordás, Ingrid, Rimola, Jordi
Publicado 2022

Clinically reversible ustekinumab-induced encephalopathy: case report and review of the literature

por Sarto, Jordi, Caballol, Berta, Berenguer, Joan, Aldecoa, Iban, Carbayo, Álvaro, Santana, Daniel, Archilla, Ivan, Gaig, Carles, Graus, Francesc, Panés, Julián, Saiz, Albert
Publicado 2022

Mirikizumab-Induced Transcriptome Changes in Ulcerative Colitis Patient Biopsies at Week 12 Are Maintained Through Week 52

por Johnson, Travis, Steere, Boyd, Zhang, Pengyue, Zang, Yong, Higgs, Richard, Milch, Catherine, Reinisch, Walter, Panés, Julian, Huang, Kun, D'Haens, Geert, Krishnan, Venkatesh
Publicado 2023

Evaluation of the Cross-reactivity of Antidrug Antibodies to CT-P13 and Infliximab Reference Product (Remicade): An Analysis Using Immunoassays Tagged with Both Agents

por Reinisch, Walter, Jahnsen, Jørgen, Schreiber, Stefan, Danese, Silvio, Panés, Julián, Balsa, Alejandro, Park, Won, Kim, JiSoo, Lee, Jee Un, Yoo, Dae Hyun
Publicado 2017

Tofacitinib in Patients with Ulcerative Colitis: Inflammatory Bowel Disease Questionnaire Items in Phase 3 Randomized Controlled Induction Studies

por Dubinsky, Marla C, DiBonaventura, Marco, Fan, Haiyun, Bushmakin, Andrew G, Cappelleri, Joseph C, Maller, Eric, Thorpe, Andrew J, Salese, Leonardo, Panés, Julian
Publicado 2020

Long‐term safety and tolerability of oral tofacitinib in patients with Crohn’s disease: results from a phase 2, open‐label, 48‐week extension study

por Panés, Julián, D’Haens, Geert R., Higgins, Peter D. R., Mele, Linda, Moscariello, Michele, Chan, Gary, Wang, Wenjin, Niezychowski, Wojciech, Su, Chinyu, Maller, Eric
Publicado 2019

Outcomes of Tofacitinib Dose Reduction in Patients with Ulcerative Colitis in Stable Remission from the Randomised RIVETING Trial

por Vermeire, Séverine, Su, Chinyu, Lawendy, Nervin, Kobayashi, Taku, Sandborn, William J, Rubin, David T, Modesto, Irene, Gardiner, Sean, Kulisek, Nicole, Zhang, Haiying, Wang, Wenjin, Panés, Julian
Publicado 2020

Inflammatory bowel disease integral care units: Evaluation of a nationwide quality certification programme. The GETECCU experience

por Barreiro‐de Acosta, Manuel, Gutiérrez, Ana, Zabana, Yamile, Beltrán, Belén, Calvet, Xavier, Chaparro, María, Domènech, Eugeni, Esteve, Maria, Panés, Julian, Gisbert, Javier P., Nos, Pilar
Publicado 2021